1. Home
  2. FKWL vs GANX Comparison

FKWL vs GANX Comparison

Compare FKWL & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Wireless Corp.

FKWL

Franklin Wireless Corp.

N/A

Current Price

$2.43

Market Cap

27.0M

Sector

Utilities

ML Signal

N/A

Logo Gain Therapeutics Inc.

GANX

Gain Therapeutics Inc.

HOLD

Current Price

$1.82

Market Cap

76.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FKWL
GANX
Founded
1981
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.0M
76.8M
IPO Year
1997
2021

Fundamental Metrics

Financial Performance
Metric
FKWL
GANX
Price
$2.43
$1.82
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$6.00
★ $7.50
AVG Volume (30 Days)
10.1K
★ 328.2K
Earning Date
05-15-2026
05-13-2026
Dividend Yield
★ 1.10%
N/A
EPS Growth
★ 94.12
31.46
EPS
★ N/A
N/A
Revenue
★ $46,086,901.00
$55,180.00
Revenue This Year
N/A
N/A
Revenue Next Year
$7.14
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 49.65
N/A
52 Week Low
$2.21
$1.53
52 Week High
$5.48
$4.34

Technical Indicators

Market Signals
Indicator
FKWL
GANX
Relative Strength Index (RSI) 49.01 48.30
Support Level $2.21 $1.71
Resistance Level $2.48 $1.85
Average True Range (ATR) 0.06 0.08
MACD -0.00 0.01
Stochastic Oscillator 40.00 38.83

Price Performance

Historical Comparison
FKWL
GANX

About FKWL Franklin Wireless Corp.

Franklin Wireless Corp is a provider of wireless solutions, including mobile hotspots, routers, and modems, as well as hardware and software products that support machine-to-machine (M2M) applications and the Internet of Things (IoT). Its M2M and IoT solutions include embedded modules, modems, and gateways built to deliver reliable always-on connectivity supporting a spectrum of applications. These products are designed to solve wireless connectivity challenges in a range of vertical markets, including video surveillance, digital signage, home security, oil and gas exploration, kiosks, fleet management, smart grid, vehicle diagnostics, and telematics.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company's clinical stage product candidate, GT-02287, is being developed for the treatment of Parkinson's disease with and without GBA1 mutations. The Company generated an extensive preclinical data package providing evidence of the mechanism of action.

Share on Social Networks: